文献速递妇科

临床相关浓度的辛伐他汀影响人子宫肌瘤生长与细胞外基质生成

Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production.
PubMed 文献 · Fertil Steril · 2018-01-01

本研究采用二维和三维细胞培养,观察治疗浓度辛伐他汀对永生化人子宫肌瘤细胞及患者配对子宫肌层细胞的作用。辛伐他汀对两类细胞均呈浓度依赖性抗增殖,但在较低浓度下对肌瘤细胞抑制更强;10⁻⁹ mol/L 暴露48小时内即显著抑制多种细胞外基质蛋白表达。作者认为辛伐他汀可能成为子宫肌瘤的新治疗策略。

要点

  • 辛伐他汀对子宫肌瘤细胞和配对子宫肌层细胞均呈浓度依赖性抗增殖作用。
  • 较低浓度辛伐他汀对肌瘤细胞的抑制作用高于配对子宫肌层细胞。
  • 辛伐他汀浓度依赖性增加caspase-3活性,并抑制多种细胞外基质蛋白表达。

核心结论

  • 辛伐他汀在低浓度下诱导子宫肌瘤细胞凋亡,表现为活性caspase水平升高。
  • 抑制细胞外基质蛋白生成可能导致肿瘤体积缩小。
  • 作者认为辛伐他汀可能成为子宫肌瘤的一种新治疗策略。

研究设计与样本

  • 二维和三维细胞培养研究,使用永生化人子宫肌瘤细胞及患者配对的子宫肌层细胞。
  • 研究在大学实验室进行,无患者参与,无干预措施。
  • 主要结局指标为细胞增殖、凋亡信号通路改变及细胞外基质蛋白生成。

主要发现

  • 辛伐他汀对肌瘤细胞和配对子宫肌层细胞均呈浓度依赖性抗增殖作用。
  • 较低浓度辛伐他汀对肌瘤细胞的抑制作用高于配对子宫肌层细胞。
  • 辛伐他汀通过浓度依赖性增加caspase-3活性调控肌瘤细胞凋亡。
  • 辛伐他汀在低至10⁻⁹ mol/L浓度、暴露48小时内显著抑制肌瘤细胞中胶原I、胶原III、纤连蛋白、versican和brevican等主要细胞外基质蛋白的表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To observe the antifibroid effects of therapeutic concentrations of simvastatin, which interferes with cholesterol biosynthesis, a known precursor of five major classes of steroid hormones, including progesterone and estrogen, which play a major role in the development and growth of uterine leiomyomas. DESIGN: Two-dimensional and three-dimensional cell culture study of immortalized human leiomyoma and patient-matched myometrium cells treated with simvastatin. SETTING: University laboratory. PATIENT(S): None. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): Cell proliferation, alteration in apoptotic signaling pathways, and extracellular matrix (ECM) protein production. RESULT(S): Simvastatin demonstrated a concentration-dependent antiproliferative effect on both the leiomyoma cells and the patient-matched myometrium cells, but a higher inhibitory effect at lower concentrations of simvastatin was observed in leiomyoma cells. Simvastatin also regulated leiomyoma cell apoptosis through a concentration-dependent increase in activity of caspase-3. Simvastatin significantly inhibited expression of major ECM proteins collagen I, collagen III, fibronectin, versican, and brevican in leiomyoma cells at concentrations as low as 10-9 mol/L within 48 hours of exposure. CONCLUSION(S): Simvastatin induces apoptosis in uterine leiomyoma cells at low concentrations, as evidenced by increased active caspase levels. Furthermore, inhibited production of the ECM proteins may lead to reduction in tumor size. Simvastatin may represent a novel therapeutic treatment strategy for uterine leiomyomas.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Malik M, Britten J, Borahay M, et al. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production. Fertil Steril. 2018. PMID: 30503138. doi:10.1016/j.fertnstert.2018.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。